TheraRadar
← Back
Data updated: Mar 29, 2026

BLUEPRINT MEDICINES

OncologyGastroenterology
Pharma

BLUEPRINT MEDICINES is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include AYVAKIT.

2020
Since
2
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

AYVAKIT
avapritinib
CSF1R 6 indications · 2020
GAVRETO
pralsetinib
DDR1 2 indications · 2020

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Competitive Matchups Pro

Loading...

Recent Activity

GAVRETO 2025-12-22
Labeling
AYVAKIT 2024-11-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 64%
1 drugs Phase 2: 1 Phase 1: 10
Gastroenterology 36%
1 drugs Phase 1: 4

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology
Takeda big-pharma
Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology